Personalized Cognitive Model to Reduce Behavioral and Psychological Symptoms in Dementia Patients in Nursing Homes

What this Trial Is About

Researchers are evaluating the Cognitive Model for Behavioral Interventions CoMBI, a personalized, non-drug approach designed to reduce behavioral and psychological symptoms of dementia BPSD in people living in nursing homes. This study also aims to see if CoMBI can lessen caregiver burden and improve quality of life for those with dementia. The study will explore how personal factors like personality, gender, cognitive impairment, and dementia stage may affect CoMBIs impact. Participants will receive care in residential long-term care facilities where staff are trained to use CoMBI. This intervention involves caregivers observing symptoms, identifying core needs based on personality profiles, and applying tailored strategies to modify the environment and caregiver responses. The study uses a stepped-wedge cluster randomized design where all units start with usual care and transition sequentially to CoMBI. Care plans are regularly updated by the care team. Participants will be assessed every four weeks using tools like the Neuropsychiatric Inventory Questionnaire NPI-Q, Qualidem, Montreal Cognitive Assessment, and Global Deterioration Scale. Personality questionnaires will also be completed to understand core needs. Researchers will monitor symptom severity, quality of life, cognitive function, and personality functioning before and after CoMBI training to measure outcomes over time.

Cognitive Model for Behavioral Interventions as a Non-pharmacological Intervention for Behavioral and Psychological Symptoms of Dementia